期刊文献+

糖尿病维持性血透患者的贫血及相关因素分析 被引量:1

Anemia in patients with diabetic nephropathy and maintenance hemodialysis
下载PDF
导出
摘要 目的探讨糖尿病维持性血液透析(MHD)患者贫血情况及其相关因素。方法选择97例MHD患者,其中糖尿病组30例,非糖尿病组67例,收集患者相关临床资料,采用t检验及率的显著性检验,分析糖尿病MHD患者贫血情况及其与微炎症、低蛋白血症、缺铁、继发性甲状旁腺功能亢进(SHPT)等临床因素的关系。结果 1)与非糖尿病组比较,糖尿病组贫血发生率显著升高(P<0.01),HGB水平显著降低(P<0.05)。糖尿病组与非糖尿病组rHu-EPO剂量无显著差异(P>0.05)。2)与非糖尿病组比较,糖尿病组微炎症发生率、CRP水平显著升高(P均<0.05),继发性甲状旁腺功能亢进发生率、PTH水平显著降低(P分别<0.01,0.05),ALB水平显著降低(P<0.05)。两组在缺铁、低蛋白血症等发生率及SF水平无显著差异(P均>0.05)。结论在每周使用同样剂量rHuEPO的情况下,糖尿病MHD患者贫血发生率高,贫血更明显。贫血可能与慢性炎症、营养不良有关。 Objective To analyze the characteristics of anemia in maintenance hemodialysis (MHD) patients with diabetes and its relevant factors. Methods 97 MHD patients which included 30 diabetes and 67 non-diabetes were enrolled. Clinical materials were collected. T test were used. Results 1) In the diabetes group,the incidence of anemia was significantly higher,and the level of serum albumin was lower than those in the non-diabetes group (P0.05).The rHuEPO dose had no significant difference between two groups (P0.05).2) In the diabetes group,the incidence of micro-inflammation and the level of CRP were significantly higher,the incidence of SHPT and the level of PTH were lower,and the level of serum albumin was lower than those in the non-diabetes group (P0.05). Iron deficiency had no significant difference between two groups (P0.05).Conclusions The incidence of anemia is high and anemia is obvious in MHD patients with diabetes,which is associated with chronic inflammation and malnutrition.
出处 《齐齐哈尔医学院学报》 2010年第15期2363-2365,共3页 Journal of Qiqihar Medical University
关键词 糖尿病 血液透析 贫血 Diabetes mellitus Renal dialysis Anemia
  • 相关文献

参考文献10

  • 1中华医学会肾脏病分会透析移植登记工作组,钱家麒,张伟明,徐筱琪.1999年度全国透析移植登记报告[J].中华肾脏病杂志,2001,17(2):77-78. 被引量:441
  • 2New JP,Aung T,Baker PG,et al.The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease:A population-based study[J].Diabet Med,2008,(5):564-569.
  • 3Sasso FC,De Nicola L,Carbonara O,et al.Cardiovascular Risk Factors and Disease Management in Type 2 Diabetic Patients With Diabetic Nephropathy[J].Diabetes Care,2006,29(3):498-503.
  • 4National Kidney Foundation:K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease:Update 2000[J].Am J Ki dney Dis,2001(suppl 1),37:S182-238.
  • 5钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量:2312
  • 6占锦峰,刘志红,谢红浪,葛永纯,张培培,张馨,鲍浩,黎磊石.糖尿病肾病患者贫血的特点及其相关因素分析[J].肾脏病与透析肾移植杂志,2007,16(6):516-521. 被引量:18
  • 7Trey JE,Kushner I.The acute phase response and the hematopoietic system:The role of cytokines[J].Crit Rev Oncol Hematol.1995,21:1-18.
  • 8Nemeth E,Rivera S,Gabayan V,et al.IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin[J].J Clin Invest,2004,113:1271-1276.
  • 9Thomas MC,MacIsaac RJ,Tsalamandris C,et al.Elavated iron indices in patients with diabetes[J].Diabet Med,2004,21(7):798-802.
  • 10Guenter W,Goodnough LT.Anemia of chronic disease[J].N Engl J Med,2005,352(10):1011-1023.

二级参考文献12

  • 1Levey AS, Greene T, Kusek JW, et al. A simplifyied equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol, 2001, 11 : A0828 (abstract).
  • 2Rossing P, Rossing K, Gaede P, et al. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care, 2006, 29: 1024- 1030.
  • 3Thomas MC, Thomas M, Tsalamandris, Maxzsaac, et al. Anemia in diabetes : an emerging complication of microvaseular disease. Current Diabet Rev, 2005, ( 1 ) : 107 - 126.
  • 4Sinclair SH. Diabetic macular edema: New concepts of pathology and treatment. Semin Ophthalmol, 1999, 14: 197- 199.
  • 5Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neo- vascularization in vivo by inhibition of vascular endothelial growth factor (VEFG) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA,1995, 92:10457 - 10461.
  • 6Friedman EA, LEsperance FA, Brown CD, et al. Treating azotemiainduced anemia with erythropoietin improves diabetic eye disease. Kidney Int,2003, (Suppl) (87), S57 - 63.
  • 7Berman DH, Friedman EA. Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythrepoietin. Retina, 1994, 14 : 1 - 5.
  • 8Friedman EA, Brown CD, Berman DH. Erythropoietin in diabetic macular edema and renal insufficiency. Am J Didney Dis, 1995,26: 202 - 208.
  • 9Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in nor- motensive men with wen-controlled type 2 diabetes: importantce of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 2001,2:5 - 10.
  • 10Sarnak MJ, Leey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease. High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, 2003,108 : 254 - 2169.

共引文献2765

同被引文献9

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部